Automated Tele Counseling for Screening Mammography
The primary goal of this project is to evaluate the effectiveness and acceptability of a
computer-based telecommunications system for increasing rates of regular screening
mammography among women ages 50-74. The Telephone-Linked-Communications for Mammography
Screening (TLC-M) is designed to educate, advise and motivate women to have regular
screening mammograms. There will be two versions of TLC-M: one for women who are coming due
for their annual screening mammography ("pre-due" women) and one for women who have missed
their annual mammogram ("past-due" women). TLC-M uses a real human voice to speak to the
women on the telephone; the subjects communicate by using the touch tone keypad on their
telephones. The intervention will consist of up to three automated telephone conversations.
During the call TLC-M assesses the woman's willingness to have a mammogram, helps interested
women schedule a mammogram, and identifies and addresses difficulties or barriers she might
have in getting a mammogram. This study will consist of two linked randomized controlled
trials. We will recruit 2,120 participants over 12 months from two radiology departments.
Three to four months prior to their due date for an annual screening mammogram, these women
will receive a reminder letter to schedule a mammogram. In addition, a random sample of them
will use TLC-M. All participants in this "pre-due" intervention study will be evaluated 3
months after their due date to determine whether or not they obtained a mammogram. Of the
women who received the letter only in the first trial, those who did not obtain a mammogram
during the observation period will enter a "past due" intervention trial. These women will
be randomly assigned to receive a "past due" reminder letter or to use the TLC-M. Four
months later, participants will be evaluated to determine whether they had a mammogram. For
both trials mammography rates of those women who used the TLC-M and those who did not will
be statistically compared.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind
Number of women who have repeat screening mammogram
Robert Friedman, MD
Principal Investigator
Boston University
United States: Institutional Review Board
R01-CA84447-01
NCT00247013
January 1996
January 2006
Name | Location |
---|---|
Boston Medical Center | Boston, Massachusetts 02118 |